Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients

NCT01515657 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: PL2200 Aspirin Capsules
DRUG: Immediate-Release Aspirin Tablets
DRUG: Enteric-coated aspirin caplets

Sponsor

PLx Pharma